Prospector Partners »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Prospector Partners

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Prospector Partners from 13F filings

Historical chart of Prospector Partners investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Prospector Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Prospector Partners

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.3M 1.2M 1.11
2024-03-31 $972k 1.0M 0.97

More positions owned by Prospector Partners

Leidos Holdings (LDOS)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Brown & Brown (BRO)
Progressive Corporation (PGR)
Curtiss-Wright (CW)
Exxon Mobil Corporation (XOM)
Eaton Corp SHS (ETN)
Arthur J. Gallagher & Co. (AJG)
Merck & Co (MRK)
Trimble Navigation (TRMB)
Abbott Laboratories (ABT)
Littelfuse (LFUS)
Primerica (PRI)
Globe Life (GL)
Carrier Global Corporation (CARR)

View all positions for Prospector Partners

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

M&G
Citadel Advisors
MacKay Shields
Lazard Asset Management
Calamos Advisors
Polar Securities
BlackRock
Wolverine Asset Management
Ing Investment Management
Wells Fargo & Company
CNH Partners
State Street Corporation
BlackRock
Absolute Investment Advisers
Glazer Capital

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1